Wikidata entity: Q13896859
Quantities
| P2067 | mass | 149000 |
| P3780 | active ingredient in | ... | Q29006084 (Keytruda) | Keytruda |
| P1552 | has characteristic | ... | Q679692 (biopharmaceutical) | biopharmaceutical |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Pembrolizumab%205DK3.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284878 (Լյարդի ախտահարման հավանականության E կատեգորիա) | Լյարդի ախտահարման հավանականության E կատեգորիա |
| P2175 | medical condition treated | ... | Q180614 (melanoma) | melanoma |
| P2175 | medical condition treated | ... | Q504775 (bladder cancer) | bladder cancer |
| P2175 | medical condition treated | ... | Q1711744 (Merkel cell carcinoma) | Merkel cell carcinoma |
| P2175 | medical condition treated | ... | Q2501186 (transitional cell carcinoma) | transitional cell carcinoma |
| P2175 | medical condition treated | ... | Q3658562 (non-small-cell lung carcinoma) | non-small-cell lung carcinoma |
| P2175 | medical condition treated | ... | Q5749020 (squamous cell carcinoma of the lung) | squamous cell carcinoma of the lung |
| P2175 | medical condition treated | ... | Q18348812 (head and neck squamous cell carcinoma) | head and neck squamous cell carcinoma |
| P2175 | medical condition treated | ... | Q1164529 (renal cell carcinoma) | renal cell carcinoma |
| P2175 | medical condition treated | ... | Q18555025 (colon cancer) | colon cancer |
| P2175 | medical condition treated | ... | Q18555143 (benign mesothelioma) | benign mesothelioma |
| P2175 | medical condition treated | ... | Q18556148 (bladder urothelial carcinoma) | bladder urothelial carcinoma |
| P2175 | medical condition treated | ... | Q18975855 (metastatic melanoma) | metastatic melanoma |
| P2175 | medical condition treated | ... | Q28757362 (tongue squamous cell carcinoma) | tongue squamous cell carcinoma |
| P129 | physically interacts with | ... | Q21208025 (programmed cell death 1) | programmed cell death 1 |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q422248 (monoclonal antibody) | monoclonal antibody |
| P2868 | subject has role | ... | Q50429626 (immunological antineoplastic agent) | immunological antineoplastic agent |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | pembrolizumab | ??? |
| P267 | ATC code | L01XC18 |
| P231 | CAS Registry Number | 1374853-91-4 |
| P592 | ChEMBL ID | CHEMBL3137343 |
| P715 | DrugBank ID | DB09037 |
| P232 | EC number | 807-012-2 |
| P2566 | ECHA Substance Infocard ID | 100.234.370 |
| P9635 | electronic Essential Medicines List medicine ID | 565 |
| P646 | Freebase ID | /m/0tkhdkd |
| P595 | Guide to Pharmacology Ligand ID | 7499 |
| P2062 | HSDB ID | 8257 |
| P665 | KEGG ID | D10574 |
| P7830 | LiverTox ID | Pembrolizumab |
| P10245 | MedlinePlus drug identifier | a614048 |
| P486 | MeSH descriptor ID | C582435 |
| P6366 | Microsoft Academic ID (discontinued) | 2780057760 |
| P2115 | NDF-RT ID | N0000191088 |
| P10283 | OpenAlex ID | C2780057760 |
| P662 | PubChem CID | 254741536 |
| P2153 | PubChem Substance ID (SID) | 254741536 |
| P3417 | Quora topic ID | Pembrolizumab |
| P3345 | RxNorm CUI | 1547545 |
| P4527 | UK Parliament thesaurus ID | 494877 |
| P2892 | UMLS CUI | C3658706 |
| P652 | UNII | DPT0O3T46P |
| P11143 | WikiProjectMed ID | Pembrolizumab |
| P2347 | YSO ID | 39037 |
Why not click here or view trends?
log id: 2662459